CPIG
MGNX icon

Chicago Partners Investment Group’s MacroGenics MGNX Stock Holding History

Chicago Partners Investment Group’s Portfolio MGNX Stock Details MGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-10,262
Closed -$32K – 612
2022
Q2 		$32K Buy
+10,262
New +$53.9K ﹤0.01% 585
2021
Q2 		– Sell
-8,128
Closed -$284K – 550
2021
Q1 		$284K Buy
+8,128
New +$197K 0.02% 410

Other funds holding MGNX

BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Chicago Partners Investment Group's MGNX Position: Q3 2022 in Review

Chicago Partners Investment Group sold out of MacroGenics (MGNX) in Q3 2022, closing a stake of 10,262 shares — an estimated $32K sold.

Chicago Partners Investment Group first reported a position in MGNX in Q1 2021 and held it in 2 quarters. The position peaked at $284K in Q1 2021. 135 funds tracked by Wall St. Rank hold MGNX as of Q3 2022.

  • Chicago Partners Investment Group reported no remaining MacroGenics position as of Q3 2022 after selling out during the quarter.
  • Chicago Partners Investment Group sold 10,262 MacroGenics shares in Q3 2022, an estimated $32K.
  • Chicago Partners Investment Group first reported a position in MacroGenics in Q1 2021 and held it in 2 quarters.
  • Chicago Partners Investment Group's MacroGenics position peaked at $284K in Q1 2021.
  • 135 funds tracked by Wall St. Rank held MacroGenics as of Q3 2022.

Based on Chicago Partners Investment Group's 13F filing for Q3 2022, filed 9 Nov 2022.